Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06122220

Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.

Optic Nerve Sheath Measurement and Angiogenic Factors for the Diagnosis of Pre-eclampsia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Saint Thomas Hospital, Panama · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit. Refining the diagnostic capability of this test would further improve maternal-fetal outcomes and the use of optic nerve sheath diameter (ONSD) measurement could make the difference. The purpose of the present study is to correlate the measurement of ONSD with serum angiogenic factor (AF) values in patients with pre-eclampsia and to determine its predictive ability for adverse perinatal outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDUREONSD+AFMeasurement of the optic nerve sheath diameter and of sFLT-1/PGIF index

Timeline

Start date
2025-08-15
Primary completion
2025-12-31
Completion
2026-01-30
First posted
2023-11-08
Last updated
2025-08-26

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT06122220. Inclusion in this directory is not an endorsement.